Marksans Pharma Cetirizine Hydrochloride Tablets get USFDA okay
Mumbai: Marksans Pharma Limited today announced that the company has received final approval from US Food & Drugs Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for over the counter (OTC) Cetirizine
Hydrochloride Tablets 5 mg and 10mg.
It is indicated for the treatment of the perennial allergic rhinitis including sneezing, rhinorrhea, postnasal discharge, watery eyes, running nose.
The product will be marketed under store brand labels and is comparable to the brand Zyrtec.
Read also: UK MHRA okays Marksans Pharma anti-diarrhoea drug Loperamide
Marksans Pharma, headquartered at Mumbai (India) is a global pharmaceutical company.
The company's key focus areas lie in the OTC & prescription drugs that have wide-ranging applications across fields like Oncology, Gastroenterology, Antidiabetic, Antibiotics, Cardiovascular, Pain Management, Gynaecology, among others.
Read also: Marksans Pharma gets USFDA nod for Acetaminophen ER Tablets
